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Summary
Autosomal dominant retinitis pigmentosa (ADRP) has recently been linked to locus D3S47 (probe C17),
with no recombination, in a single large Irish family. Other ADRP pedigrees have shown linkage at zero
recombination, linkage with recombination, and no linkage, demonstrating genetic heterogeneity. The gene
encoding rhodopsin, the rod photoreceptor pigment, is closely linked to locus D3S47 on chromosome 3q.
A point mutation changing a conserved proline to histidine in the 23d codon of the gene has been demon-
strated in affected members of one ADRP family and in 17 of 148 unrelated ADRP patients. We have se-
quenced the rhodopsin gene in a C17-linked ADRP family and have identified in the 4th exon an in-frame
3-bp deletion which deletes one of the two isoleucine monomers at codons 255 and 256. This mutation
was not found in 30 other unrelated ADRP families. The deletion has arisen in the sequence TCATCAT-
CAT, deleting one of a run of three x 3-bp repeats. The mechanism by which this occurred may be simi-
lar to that which creates length variation in so-called mini- and microsatellites. Thus ADRP is an ex-
tremely heterogeneous disorder which can result from a range of defects in rhodopsin and which can have
a locus or loci elsewhere in the genome.
Introduction
Retinitis pigmentosa (RP) is a term used to denote a
collection of genetically determined disorders causing
slow outer-retinal degeneration. Clinical characteris-
tics include night blindness, constriction of visual fields,
an abnormal fundus appearance, narrowed retinal ves-
sels, and depression of the normal ocular electrophysio-
logical responses (Merin and Auerbach 1976). The
condition affects about 1/5,000 people in the United
Kingdom, though estimates vary. RP can be further sub-
divided into autosomal dominant, autosomal recessive,
and X-linked cases, which accounted for 22%, 10%,
and 14% of patients, respectively in a recent survey (Bun-
dey and Crews 1984). Of the remainder, 17% had au-
tosomal recessive syndromes including RP, while 37%
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were unclassified. Attempts have been made to subdi-
vide ADRP further on the basis of age at onset, degree
of gene penetrance, differential effects on rod and cone
sensitivity, and distribution of pigment in the affected
retina (Berson et al. 1969; Massof and Finkelstein 1979,
1981; Lyness et al. 1985). The now prevalent hypothe-
sis subdivides ADRP into two categories, known as D
type (diffuse) or type 1 ADRP, and R type (regional),
or type II (Massof and Finkelstein 1981; Lyness et al.
1985). D-type ADRP leads to diffuse and severe loss
of rod function early in life, but with relatively good
preservation of cone function. Night blindness is con-
sistently recognized before the age of 10 years, although
pigmentary changes may not be evident until the sec-
ond or third decade. The R-type disease shows patchy
and equal loss of cone and rod function, with substan-
tial variation in age at onset, both between and within
affected families. Variants within the R-type category
have been described with respect to variable expressivity,
sectorial RP, and slow adaptation to darkness (Alex-
ander and Fishman 1984; Fulton and Hansen 1988).
Linkage to locus D3S47 (probe C17) on chromosome
3q has recently been demonstrated in a single large Irish
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D-type ADRP family (TCDM1; McWilliam et al. 1989).
The use of large families removes any problems as-
sociated with pooling lod scores in a heterogeneous dis-
order. The lod score of 14.7 with no recombination
demonstrated very tight linkage. A further D-type fam-
ily, ADRP3, has been shown to have linkage with no
recombination (Lester et al. 1990), while two large
R-type families have no linkage on chromosome 3q (In-
glehearn et al. 1990; Lester et al. 1990). However, an
R-type family has been shown to be linked at a recom-
bination fraction of .08 (Olsson et al. 1990), raising
the possibility of a second ADRP locus close by. The
observed linkage led Dryja and co-workers to carry out
genomic sequencing on the rhodopsin gene, also on
3q (Nathans et al. 1986), inADRP patients. It was found
that a CCC-to-CAC point mutation, changing a con-
served proline to a histidine, was the likely cause of
ADRP in about 12% of patients in a North American
population (Dryja et al. 1990). We therefore analyzed
the rhodopsin gene in two British families in which
ADRP is known to be linked to C17. In one family
(ADRP3, as described by Lester et al. 1990), we have
found no mutations to date. In the other family
(ADRP14), we identified a 3-bp deletion which is al-
most certainly the cause of ADRP in this pedigree.
Patients and Methods
Family ADRP14 shows linkage between the disorder
and C17, with a lod score of 2.7 with no recombina-
tion. The disorder presents in early life, all affected mem-
bers having had night blindness for as long as they could
remember. Visual difficulties by day were not apparent
until the third decade of life, and good visual acuity
was retained until the seventh or eighth decade of life.
Visual field restriction was apparent by the age of 20
years, but even in the seventh decade of life a scotopic
field of 5°-10° was present. The ocular fundi showed
irregularity of pigment in the retinal pigment epithe-
lium, with areas of hypo- and hyperpigmentation. Pig-
ment migration into the neuroretina was sparse even
in late life. Patchy choroidal atrophy was evident by the
age of 30 years and was widespread in the affected areas
by the mid sixties. The macular appearance remained
relatively normal into late life, with sharp demarcation
between the affected and unaffected retina. These char-
acteristics imply that the ADRP was class I or diffuse,
although this has yet to be verified by psychophysical
testing.
Genomic DNAs from members of affected pedigrees
were prepared by a method based on that described by
Herman and Frischauf (1987). Amplification of rho-
dopsin exons by polymerase chain reaction (Saiki et al.
1988) was carried out using NBL Taq polymerase in
the manufacturers buffer, with 30 cycles of 1 min at
91°C, 1 min at 550C, and 2.5 min at 720C. Oligomers
used for amplification and sequencing of the exons were
all 20-mers with 10 or more C/G residues, to give a
Td (dissociation temperature) equal to or greater than
60°C (Td = 4(G+C) + 2(A+T); Thein and Wallace
1986). Sequencing was carried out using combinations
of oligomers such that the sequencing primer was differ-
ent from those used to amplify and was therefore inter-
nal on the amplified molecule. Amplified sequences were
treated with proteinase K, cleaned by extraction with
phenol, phenol and chloroform, and chloroform, and
then run through a Sepharose CL6B column (Pharma-
cia), according to a method described by Yandell and
Dryja (1989). The primer was kinase end-labeled by
the method of Chaconas and Van Der Sande (1980).
Ten microliters of primer (2 pmol) andDNA (100-500
ng) were heated to 940C for 3 min and then cooled
on ice for 1 min. Sequencing was then carried out using
T7 DNA polymerase (Sequenase) according to the
manufacturer's (USB) instructions. Reactions were
analyzed by separation on a 6% polyacrylamide wedge-
sequencing gel. Dot blot analysis was carried out ac-
cording to a method described elsewhere (Lester et al.
1990), with hybridization and washing at approximately
40C below the melting temperature of the correctly
aligned oligomer. The 100-bp PCR designed to visual-
ize the deletion was performed as described above, but
with 30 cycles of 30 s at 910C, 30 s at 500C, and 1
min at 720C. Products of this PCR were visualized on
a 10% polyacrylamide gel.
Results
Genomic sequencing of an affected member of fam-
ily ADRP14 revealed a 3-bp deletion in the fourth exon
of a patient from this family (fig. 1). This deletes one
of two isoleucine monomers, at codons 255 and 256,
from the sixth transmembrane hydrophobic segment
of the rhodopsin molecule (fig. 2). We then synthesized
20-bp oligomers spanning codons 255 and 256, one
oligomer with the normal and one with the mutant
sequence. By hybridizing these oligomers separately
to PCR-amplified fourth exon from all members of
ADRP14, we demonstrated that the mutation is pres-
ent in nine affected members and is absent in eight
unaffected blood relatives (fig. 3). As further confirma-
tion of the presence of a deletion in this family, oligos
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Figure I Sequencing gel showing sequence across point of de-
letion in family ADRP14, together with normal sequence, which is
seen at this point in family ADRP3. The line in the written sequence
at the center denotes the point from which the deletion is apparent.
From that point upward, two sequences can be seen superimposed
on one another, one being the correct one and the other being a 3-bp
frameshifted one.
ACAGAAGGCAGAGAAGGAGG and GAAGATGTA-
GAATGCCACGC, which flank the deletion, giving a
normal PCR product of exactly 100 bp, were used to
amplify DNA from normal and affected individuals (fig.
4). Normal individuals have only one band, while
affected members can be seen to have a second band,
3-bp smaller than the normal sequence. In the same
way we were able to exclude deletion or insertion in
this part of the rhodopsin gene in a panel of 30 un-
related ADRP patients from affected pedigrees, four pa-
tients with other forms of inherited retinal degenera-
tion, and 43 normal controls. Twenty-four of these
families had previously been screened by oligo-hybridi-
zation for the presence of the codon 23 CCC--CAC
INTRADICAL DOMAIN
NORMAL SEQUENCE
250 255 256 260
Lys Glu Val Thr Arg Met Val Ile Ile Met Val Ile Ala Ph. Leu Ile
---AAG GAG GTC ACC CGC ATG GTC ATC ATC ATG GTC ATC GCT TTC CTG ATC---
---TTC CTC CAG TGG GCG TAC CAG TAG TAG TAC CAG TAG CGA AAG GAC TAG---
MUTANT SEQUENCE V
Thr Are Met Val Ile Met Val Ile Ala
-----------ACC CGC ATO GTC ATC ATG GTC ATC GCT----- -
--------------TGG GCG TAC CAG TAG TAC CAG TAG CGA - -
Figure 2 Top, Diagrammatic representation of rhodopsin mol-
ecule, showing location of codon 23 and codon 255 mutations. Shaded
circles represent evolutionarily conserved amino acids (Applebury
and Hargreave 1986). Bottom, Nucleotide and amino acid sequences
of normal and mutant rhodopsin gene, at point of deletion. Oligomers
used to detect the mutation are shown in boldface.
mutation, but none were found to have it (data not
shown).
Discussion
Isoleucine residues at codons 255 and 256 are found
in bovine and human rhodopsin but are not conserved
among either the human color pigments or the visual
pigments in other species (Applebury and Hargrave
1986). However, isoleucines 255 and 256 are common
to several other receptor molecules which, like rhodop-
sin, are coupled to guanine nucleotide regulatory pro-
teins (Kobilka et al. 1987). Since the mutation deletes
an amino acid rather than substituting one, without
changing the reading frame, it will have the effect of
shortening the sixth transmembrane domain and may
therefore affect both secondary structure and function
of the gene product, beyond any significance which the
deleted amino acid may have had. Clearly, then, this
result, together with the previously reported codon 23
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Figure 3 Dot blot hybridization of the normal (upper row ofgels) and mutant (lower row ofgels) oligomers (see fig. 2) to PCR-amplified
fourth exon of rhodopsin from members of family ADRP14. The pedigree is shown above.
1 3 4 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Figure 4 Polyacrylamide gel (10%) showing the products of a 100-bp PCR spanning the deletion in various members of family ADRP14.
Numbers correspond to those on the pedigree shown in fig. 3. Normal individuals have only a slight band, while affected individuals have
a doublet, as well as a third band above which is a heterodimer of the normal and mutant strands.
mutation, demonstrates that mutations in the rhodop-
sin gene can cause ADRP.
It is interesting to speculate on the mechanism by which
this particular mutation arose. The deletion of 3 bp has
occurred within the sequence S'TCATCATCAT3'. Ex-
actly which three nucleotides have been deleted is im-
possible to tell and would make no difference to the
resultant mutation. It seems possible that the deletion
occurred by a process similar to that which creates new
length variants at microsatellite loci. Replication slip-
page at meiosis is a mechanism thought to be significant
in tandem repeats of short (1-4-bp) motifs, though un-
equal crossover is also a possible cause (Jarman and
Wells 1989). It would seem, therefore, that coding se-
quences are not exempt from the process by which such
repeats arise.
In conclusion, consistent with observations on pheno-
type, ADRP is heterogeneous at every level, with (a)
one or possibly two loci linked to C17 on chromosome
3q, (b) at least one other locus elsewhere on the auto-
somes, and (c) two or more different lesions within one
C17 linked gene, namely, rhodopsin. This is as might
be expected for a dominant defect, since natural selec-
tion would prevent any one mutation from rising to a
significant frequency in the population. That the codon
23 mutation does attain a significant frequency in a
North American population could be due to repeated
substitutions at a mutation hot spot. Alternatively, this
mutation may have arisen only once but has remained
in the gene pool for a significant time because the level
of selection against it was not high- many patients re-
tain adequate vision into later life.
Now that rhodopsin has been proved to be one loca-
tion for genetic lesions causing RP, other molecules in
the visual cascade are prime candidates in unlinked fam-
ilies, e.g., S-antigen on chromosome 2; transducin, en-
coded by genes on chromosomes 1 and 3; and retinal
binding protein 2, also on chromosome 3 (Dancinger
et al. 1989; Human Gene Mapping 10 1989). By iden-
tifying sites for ADRP mutations, it becomes possible
to provide predictive testing with absolute certainty in
some families. In addition, testing for specific defects
29
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may allow counseling in isolated cases of RP, where
linkage data are unavailable. Ultimately, knowledge of
the underlying causes ofRP which emerges from studies
such as this, together with the steady increase in our
understanding of the biochemical pathways of the
healthy retina, may lead to therapies for this debilitat-
ing genetic disorder.
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